Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety, tolerability, and efficacy of adjunctive
rosiglitazone in the treatment of uncomplicated P.falciparum malaria.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mahidol University
Collaborator:
McLaughlin-Rotman Center for Global Health, University of Toronto